Feed RSS de PHARMA JAPAN - REGULATORY -

Quem segue PHARMA JAPAN - REGULATORY - também segue

• EC Decisions concerning orphan medicinal products ec.europa.eu
• FiercePharma: Manufacturing fiercepharma.com
• FiercePharma: Marketing fiercepharma.com
• EC procedures on the change of status of human medicinal products ec.europa.eu
• G-BA: Letzte Änderungen der Website g-ba.de
• Ozempic (semaglutide) - Novo Nordisk A/S ec.europa.eu
• HAS - Bulletin officiel has-sante.fr
• Medicines and Healthcare products Regulatory Agency - Activity on GOV.UK gov.uk

Mais feeds RSS de pj.jiho.jp

• PHARMA JAPAN - Latest - https://pj.jiho.jp/article/rss.xml
• PHARMA JAPAN - BUSINESS - https://pj.jiho.jp/genre/2/rss.xml
• PHARMA JAPAN - ORGANIZATION - https://pj.jiho.jp/genre/9/rss.xml
• PHARMA JAPAN - ACADEMIA - https://pj.jiho.jp/genre/10/rss.xml
• REGULATORY | PHARMA JAPAN | GU https://rss.app/feeds/Z3Q6MgiOcCi7Y1y8.xml

Ver todos os feeds RSS de pj.jiho.jp

Ver todos os feeds RSS de Saúde

Mais feeds RSS para explorar

• ClinicalTrials.gov: RPC-1063 (ozanimod) | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days clinicaltrials.gov
• ClinicalTrials.gov: UPLIZNA | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days clinicaltrials.gov
• ClinicalTrials.gov: mezagitamab (TAK 079) | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days clinicaltrials.gov